Polycystic Kidney Diseases - 18 Studies Found

Completed : Sirolimus (Rapamune®) for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
: 2006-06-22
:
  • Drug: Sirolimus Standard plus

Recruiting : The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted Recipients
: Autosomal Dominant Polycystic Kidney Disease
: 2014-04-28
:
  • Drug: Everolimus Change from a
Completed : Water as Therapy in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
: Autosomal Dominant Polycystic Kidney Disease
: 2008-09-24
: Other: Water prescription Water prescription in 12 to 16 equally divided doses
Terminated : Sirolimus In Autosomal Dominant Polycystic Kidney Disease And Severe Renal Insufficiency
: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
: 2010-10-12
:
  • Drug: Sirolimus Patients will

Completed : A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Study 156-04-001]
: Autosomal Dominant Polycystic Kidney Disease
: 2009-02-09
: Drug: OPC-41061 orally administered at 15 mg twice daily (morning and evening) for a maximum of 3 years.
Completed : A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) (2) [Extension of Study 156-05-002]
: Autosomal Dominant Polycystic Kidney Disease
: 2009-11-27
: Drug: OPC-41061 Repeated oral administration at doses of 15 mg twice daily (morning and evening)
Terminated : Randomized Clinical Trial of Triptolide Woldifii for Autosomal Dominant Polycystic Kidney Disease
: Polycystic Kidney
: 2008-11-25
:
  • Drug: tripterygium wilfordii T
Recruiting : Triptolide-Containing Formulation as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
: 2014-04-14
:
  • Drug: Triptolide-Containing Formulation

<<< Previous